{"id":"https://openalex.org/W3023123785","doi":"https://doi.org/10.1182/blood.v130.suppl_1.392.392","title":"Next Generation Sequencing Identifies Smoldering Multiple Myeloma Patients with a High Risk of Disease Progression","display_name":"Next Generation Sequencing Identifies Smoldering Multiple Myeloma Patients with a High Risk of Disease Progression","publication_year":2017,"publication_date":"2017-12-07","ids":{"openalex":"https://openalex.org/W3023123785","doi":"https://doi.org/10.1182/blood.v130.suppl_1.392.392","mag":"3023123785"},"language":"en","primary_location":{"id":"mag:3023123785","doi":"https://doi.org/10.1182/blood.v130.suppl_1.392.392","is_oa":false,"landing_page_url":"https://ashpublications.org/blood/article/130/Supplement%201/392/71611/Next-Generation-Sequencing-Identifies-Smoldering","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Blood","raw_type":null},"volume":null,"type":"article","indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5003087873","display_name":"Mark W. Bustoros","orcid":"https://orcid.org/0000-0002-4652-5449","observed_orcids":["https://orcid.org/0000-0002-4652-5449"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark Bustoros","raw_affiliation_strings":["Medical Oncology, Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":"https://orcid.org/0000-0002-4652-5449","affiliations":[{"raw_affiliation_string":"Medical Oncology, Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100392578","display_name":"Jihye Park","orcid":"https://orcid.org/0000-0002-4451-2046","observed_orcids":["https://orcid.org/0000-0002-4451-2046"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jihye Park","raw_affiliation_strings":["Medical oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"],"raw_orcid":"https://orcid.org/0000-0002-4451-2046","affiliations":[{"raw_affiliation_string":"Medical oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052819968","display_name":"Karma Ziad Salem","orcid":"https://orcid.org/0000-0002-0246-7785","observed_orcids":["https://orcid.org/0000-0002-0246-7785"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Karma Z. Salem","raw_affiliation_strings":["Medical oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"],"raw_orcid":"https://orcid.org/0000-0002-0246-7785","affiliations":[{"raw_affiliation_string":"Medical oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101669561","display_name":"Chia\u2010Jen Liu","orcid":"https://orcid.org/0000-0001-7945-9292","observed_orcids":["https://orcid.org/0000-0001-7945-9292"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I2803004286","display_name":"Taipei Veterans General Hospital","ror":"https://ror.org/03ymy8z76","country_code":"TW","type":"healthcare","lineage":["https://openalex.org/I2803004286"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["TW","US"],"is_corresponding":false,"raw_author_name":"Chia\u2010Jen Liu","raw_affiliation_strings":["Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","Division of Hematology, Taipei Veterans General Hospital, Taipei, MA"],"raw_orcid":"https://orcid.org/0000-0001-7945-9292","affiliations":[{"raw_affiliation_string":"Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Division of Hematology, Taipei Veterans General Hospital, Taipei, MA","institution_ids":["https://openalex.org/I2803004286"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009037819","display_name":"Marzia Capelletti","orcid":"https://orcid.org/0000-0001-5095-7060","observed_orcids":["https://orcid.org/0000-0001-5095-7060","https://orcid.org/0009-0005-1654-5800"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marzia Capelletti","raw_affiliation_strings":["Medical oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"],"raw_orcid":"https://orcid.org/0000-0001-5095-7060","affiliations":[{"raw_affiliation_string":"Medical oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025000402","display_name":"Daisy Huynh","orcid":"https://orcid.org/0000-0002-4633-4570","observed_orcids":["https://orcid.org/0000-0002-4633-4570"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daisy Huynh","raw_affiliation_strings":["Medical oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"],"raw_orcid":"https://orcid.org/0000-0002-4633-4570","affiliations":[{"raw_affiliation_string":"Medical oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019802024","display_name":"Yu\u2010Tzu Tai","orcid":"https://orcid.org/0000-0001-6199-3569","observed_orcids":["https://orcid.org/0000-0001-6199-3569"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yu\u2010Tzu Tai","raw_affiliation_strings":["Medical Oncology, Dana Farber Cancer Institute/Harvard Medical School, Boston,"],"raw_orcid":"https://orcid.org/0000-0001-6199-3569","affiliations":[{"raw_affiliation_string":"Medical Oncology, Dana Farber Cancer Institute/Harvard Medical School, Boston,","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054484092","display_name":"Tarek H. Mouhieddine","orcid":"https://orcid.org/0000-0002-1190-5978","observed_orcids":["https://orcid.org/0000-0002-1190-5978"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tarek H. Mouhieddine","raw_affiliation_strings":["Medical oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"],"raw_orcid":"https://orcid.org/0000-0002-1190-5978","affiliations":[{"raw_affiliation_string":"Medical oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062509177","display_name":"Samuel S. Freeman","orcid":"https://orcid.org/0000-0001-8285-0057","observed_orcids":["https://orcid.org/0000-0001-8285-0057"]},"institutions":[{"id":"https://openalex.org/I107606265","display_name":"Broad Institute","ror":"https://ror.org/05a0ya142","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I107606265"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Samuel S. Freeman","raw_affiliation_strings":["Broad Institute of MIT and Harvard, Cambridge,, MA"],"raw_orcid":"https://orcid.org/0000-0001-8285-0057","affiliations":[{"raw_affiliation_string":"Broad Institute of MIT and Harvard, Cambridge,, MA","institution_ids":["https://openalex.org/I107606265"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039343639","display_name":"Gavin Ha","orcid":"https://orcid.org/0000-0001-7578-7272","observed_orcids":["https://orcid.org/0000-0001-7578-7272"]},"institutions":[{"id":"https://openalex.org/I107606265","display_name":"Broad Institute","ror":"https://ror.org/05a0ya142","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I107606265"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gavin Ha","raw_affiliation_strings":["Broad Institute of MIT and Harvard, Cambridge,, MA"],"raw_orcid":"https://orcid.org/0000-0001-7578-7272","affiliations":[{"raw_affiliation_string":"Broad Institute of MIT and Harvard, Cambridge,, MA","institution_ids":["https://openalex.org/I107606265"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082843187","display_name":"Justin Rhoades","orcid":"https://orcid.org/0000-0002-0630-908X","observed_orcids":["https://orcid.org/0000-0002-0630-908X"]},"institutions":[{"id":"https://openalex.org/I107606265","display_name":"Broad Institute","ror":"https://ror.org/05a0ya142","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I107606265"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Justin Rhoades","raw_affiliation_strings":["Broad Institute of MIT and Harvard, Cambridge,, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Broad Institute of MIT and Harvard, Cambridge,, MA","institution_ids":["https://openalex.org/I107606265"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075392372","display_name":"Sarah C. Reed","orcid":"https://orcid.org/0000-0003-2191-6643","observed_orcids":["https://orcid.org/0000-0003-2191-6643"]},"institutions":[{"id":"https://openalex.org/I107606265","display_name":"Broad Institute","ror":"https://ror.org/05a0ya142","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I107606265"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Sarah C. Reed","raw_affiliation_strings":["Broad Institute of MIT and Harvard, Cambridge,, MA"],"raw_orcid":"https://orcid.org/0000-0003-2191-6643","affiliations":[{"raw_affiliation_string":"Broad Institute of MIT and Harvard, Cambridge,, MA","institution_ids":["https://openalex.org/I107606265"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082138646","display_name":"Gregory Gydush","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I107606265","display_name":"Broad Institute","ror":"https://ror.org/05a0ya142","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I107606265"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gregory Gydush","raw_affiliation_strings":["Broad Institute of MIT and Harvard, Cambridge,, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Broad Institute of MIT and Harvard, Cambridge,, MA","institution_ids":["https://openalex.org/I107606265"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080467056","display_name":"Denisse Rotem","orcid":"https://orcid.org/0000-0001-5030-5919","observed_orcids":["https://orcid.org/0000-0001-5030-5919"]},"institutions":[{"id":"https://openalex.org/I107606265","display_name":"Broad Institute","ror":"https://ror.org/05a0ya142","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I107606265"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Denisse Rotem","raw_affiliation_strings":["Broad Institute of MIT and Harvard, Cambridge,, MA"],"raw_orcid":"https://orcid.org/0000-0001-5030-5919","affiliations":[{"raw_affiliation_string":"Broad Institute of MIT and Harvard, Cambridge,, MA","institution_ids":["https://openalex.org/I107606265"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007419382","display_name":"Adriana Perilla-Glen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Adriana Perilla Glen","raw_affiliation_strings":["Medical Oncology, Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology, Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075607061","display_name":"Patrick M. Henrick","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Patrick Henrick","raw_affiliation_strings":["Medical Oncology, Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology, Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000620040","display_name":"Aaron M. Caola","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aaron M. Caola","raw_affiliation_strings":["Dana\u2010Farber Cancer Institute, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana\u2010Farber Cancer Institute, Boston, MA;","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014871120","display_name":"Bradley Rivotto","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bradley Rivotto","raw_affiliation_strings":["Medical Oncology, Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology, Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113981016","display_name":"Alexandra Savell","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alexandra Savell","raw_affiliation_strings":["Medical Oncology, Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology, Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109167595","display_name":"Kimberly Noonan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kimberly Noonan","raw_affiliation_strings":["Medical Oncology, Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology, Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008397526","display_name":"Kaitlen Reyes","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kaitlen Reyes","raw_affiliation_strings":["Medical Oncology, Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology, Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009466687","display_name":"Antonio Sacco","orcid":"https://orcid.org/0000-0003-2945-9416","observed_orcids":["https://orcid.org/0000-0003-2945-9416"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Antonio Sacco","raw_affiliation_strings":["Medical oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"],"raw_orcid":"https://orcid.org/0000-0003-2945-9416","affiliations":[{"raw_affiliation_string":"Medical oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023955059","display_name":"Cody J. Boehner","orcid":"https://orcid.org/0000-0003-0238-0652","observed_orcids":["https://orcid.org/0000-0003-0238-0652"]},"institutions":[{"id":"https://openalex.org/I33434090","display_name":"University of Massachusetts Boston","ror":"https://ror.org/04ydmy275","country_code":"US","type":"education","lineage":["https://openalex.org/I33434090"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Cody J. Boehner","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA","University of Massachusetts, Boston"],"raw_orcid":"https://orcid.org/0000-0003-0238-0652","affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]},{"raw_affiliation_string":"University of Massachusetts, Boston","institution_ids":["https://openalex.org/I33434090"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076820900","display_name":"Houry Leblebjian","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Houry Leblebjian","raw_affiliation_strings":["Medical oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100739514","display_name":"David Liu","orcid":"https://orcid.org/0000-0003-0346-5033","observed_orcids":["https://orcid.org/0000-0003-0346-5033"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Liu","raw_affiliation_strings":["Medical oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"],"raw_orcid":"https://orcid.org/0000-0003-0346-5033","affiliations":[{"raw_affiliation_string":"Medical oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019671129","display_name":"Elizabeth A. Morgan","orcid":"https://orcid.org/0000-0001-5880-9337","observed_orcids":["https://orcid.org/0000-0001-5880-9337"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elizabeth A. Morgan","raw_affiliation_strings":["Brigham and Women's Hospital, Boston, MA"],"raw_orcid":"https://orcid.org/0000-0001-5880-9337","affiliations":[{"raw_affiliation_string":"Brigham and Women's Hospital, Boston, MA","institution_ids":["https://openalex.org/I1283280774"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072050682","display_name":"Aldo Maria Roccaro","orcid":"https://orcid.org/0000-0002-1872-5128","observed_orcids":["https://orcid.org/0000-0002-1872-5128"]},"institutions":[{"id":"https://openalex.org/I4210103289","display_name":"Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia","ror":"https://ror.org/015rhss58","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210103289"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Aldo M. Roccaro","raw_affiliation_strings":["Clinical Research Development and Phase I Unit, CREA Laboratory, ASST Spedali Civili di Brescia, Brescia, Italy;"],"raw_orcid":"https://orcid.org/0000-0002-1872-5128","affiliations":[{"raw_affiliation_string":"Clinical Research Development and Phase I Unit, CREA Laboratory, ASST Spedali Civili di Brescia, Brescia, Italy;","institution_ids":["https://openalex.org/I4210103289"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088396920","display_name":"Claudia E. Paba\u2010Prada","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Claudia E. Paba\u2010Prada","raw_affiliation_strings":["Harvard Medical School Dana\u2010Farber Cancer Institute Boston MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Harvard Medical School Dana\u2010Farber Cancer Institute Boston MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039044023","display_name":"Eliezer M. Van Allen","orcid":"https://orcid.org/0000-0002-0201-4444","observed_orcids":["https://orcid.org/0000-0002-0201-4444"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eliezer M. Van Allen","raw_affiliation_strings":["Medical oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"],"raw_orcid":"https://orcid.org/0000-0002-0201-4444","affiliations":[{"raw_affiliation_string":"Medical oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001076999","display_name":"John Christopher Love","orcid":"https://orcid.org/0000-0003-0921-3144","observed_orcids":["https://orcid.org/0000-0003-0921-3144"]},"institutions":[{"id":"https://openalex.org/I107606265","display_name":"Broad Institute","ror":"https://ror.org/05a0ya142","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I107606265"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christopher G. Love","raw_affiliation_strings":["Broad Institute of MIT and Harvard, Cambridge,, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Broad Institute of MIT and Harvard, Cambridge,, MA","institution_ids":["https://openalex.org/I107606265"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002786000","display_name":"Viktor A. Adalsteinsson","orcid":"https://orcid.org/0000-0003-4555-2485","observed_orcids":["https://orcid.org/0000-0003-4555-2485"]},"institutions":[{"id":"https://openalex.org/I107606265","display_name":"Broad Institute","ror":"https://ror.org/05a0ya142","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I107606265"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Viktor A. Adalsteinsson","raw_affiliation_strings":["Broad Institute of MIT and Harvard, Cambridge,, MA"],"raw_orcid":"https://orcid.org/0000-0003-4555-2485","affiliations":[{"raw_affiliation_string":"Broad Institute of MIT and Harvard, Cambridge,, MA","institution_ids":["https://openalex.org/I107606265"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049711954","display_name":"Jacob P. Laubach","orcid":"https://orcid.org/0000-0001-7565-2052","observed_orcids":["https://orcid.org/0000-0001-7565-2052"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jacob P. Laubach","raw_affiliation_strings":["Medical oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"],"raw_orcid":"https://orcid.org/0000-0001-7565-2052","affiliations":[{"raw_affiliation_string":"Medical oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109183476","display_name":"Robert L Schlossman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert Schlossman","raw_affiliation_strings":["Medical oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045740077","display_name":"Nikhil C. Munshi","orcid":"https://orcid.org/0000-0002-7344-9795","observed_orcids":["https://orcid.org/0000-0002-7344-9795","https://orcid.org/0000-0002-8397-100X"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nikhil C. Munshi","raw_affiliation_strings":["Dana-Farber Cancer Institute, Harvard Medical School, BOSTON, MA"],"raw_orcid":"https://orcid.org/0000-0002-7344-9795","affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Harvard Medical School, BOSTON, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043526996","display_name":"Paul Gerard Guy Richardson","orcid":"https://orcid.org/0000-0002-7426-8865","observed_orcids":["https://orcid.org/0000-0002-7426-8865"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paul G. Richardson","raw_affiliation_strings":["Harvard Medical School Dana\u2010Farber Cancer Institute Boston MA"],"raw_orcid":"https://orcid.org/0000-0002-7426-8865","affiliations":[{"raw_affiliation_string":"Harvard Medical School Dana\u2010Farber Cancer Institute Boston MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032464400","display_name":"Kenneth Carl Anderson","orcid":"https://orcid.org/0000-0002-6418-0886","observed_orcids":["https://orcid.org/0000-0002-6418-0886"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kenneth C. Anderson","raw_affiliation_strings":["The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"],"raw_orcid":"https://orcid.org/0000-0002-6418-0886","affiliations":[{"raw_affiliation_string":"The LeBow Institute for Myeloma Therapeutics and Jerome Lipper Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026574827","display_name":"Shaji Kunnathu Kumar","orcid":"https://orcid.org/0000-0001-5392-9284","observed_orcids":["https://orcid.org/0000-0001-5392-9284"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shaji Kumar","raw_affiliation_strings":["Division of Hematology, Mayo Clinic, Rochester, MN"],"raw_orcid":"https://orcid.org/0000-0001-5392-9284","affiliations":[{"raw_affiliation_string":"Division of Hematology, Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001392592","display_name":"Gad A. Getz","orcid":"https://orcid.org/0000-0002-0936-0753","observed_orcids":["https://orcid.org/0000-0002-0936-0753"]},"institutions":[{"id":"https://openalex.org/I107606265","display_name":"Broad Institute","ror":"https://ror.org/05a0ya142","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I107606265"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gad Getz","raw_affiliation_strings":["Broad Institute of MIT and Harvard, Cambridge,, MA"],"raw_orcid":"https://orcid.org/0000-0002-0936-0753","affiliations":[{"raw_affiliation_string":"Broad Institute of MIT and Harvard, Cambridge,, MA","institution_ids":["https://openalex.org/I107606265"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023152679","display_name":"Irene M. Ghobrial","orcid":"https://orcid.org/0000-0001-7361-3092","observed_orcids":["https://orcid.org/0000-0001-7361-3092"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Irene M. Ghobrial","raw_affiliation_strings":["Medical oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"],"raw_orcid":"https://orcid.org/0000-0001-7361-3092","affiliations":[{"raw_affiliation_string":"Medical oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5036677725","display_name":"Salomon Manier","orcid":"https://orcid.org/0000-0001-7653-711X","observed_orcids":["https://orcid.org/0000-0001-7653-711X"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Salomon Manier","raw_affiliation_strings":["Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210117453"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":8,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.1792,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":{"value":0.59677623,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"130","issue":null,"first_page":"392","last_page":"392"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11287","display_name":"Cancer Genomics and Diagnostics","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/smoldering-multiple-myeloma","display_name":"smoldering multiple myeloma","score":0.996999979019165},{"id":"https://openalex.org/keywords/monoclonal-gammopathy-of-undetermined-significance","display_name":"monoclonal gammopathy of undetermined significance","score":0.8980000019073486},{"id":"https://openalex.org/keywords/disease-progression","display_name":"disease progression","score":0.7599999904632568},{"id":"https://openalex.org/keywords/somatic-mutations","display_name":"somatic mutations","score":0.7509999871253967},{"id":"https://openalex.org/keywords/mutation-burden","display_name":"mutational burden","score":0.5640000104904175},{"id":"https://openalex.org/keywords/copy-number-alterations","display_name":"copy number alterations","score":0.5770000219345093},{"id":"https://openalex.org/keywords/chromosomal-instability","display_name":"chromosomal instability","score":0.41100001335144043},{"id":"https://openalex.org/keywords/cell-free-dna","display_name":"cell-free DNA","score":0.5130000114440918},{"id":"https://openalex.org/keywords/tumor-fraction","display_name":"tumor fraction","score":0.5609999895095825},{"id":"https://openalex.org/keywords/clonal-evolution","display_name":"clonal evolution","score":0.5040000081062317},{"id":"https://openalex.org/keywords/plasma-cell-malignancy","display_name":"plasma cell malignancy","score":0.4480000138282776},{"id":"https://openalex.org/keywords/progression-risk-prediction","display_name":"progression risk prediction","score":0.4410000145435333},{"id":"https://openalex.org/keywords/targeted-deep-sequencing","display_name":"targeted deep sequencing","score":0.6589999794960022},{"id":"https://openalex.org/keywords/germline-mutations","display_name":"germline mutations","score":0.4729999899864197}],"concepts":[{"id":"https://openalex.org/C16671776","wikidata":"https://www.wikidata.org/wiki/Q5420592","display_name":"Exome sequencing","level":4,"score":0.6935065984725952},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.6590340733528137},{"id":"https://openalex.org/C132917006","wikidata":"https://www.wikidata.org/wiki/Q5250436","display_name":"Deep sequencing","level":4,"score":0.6147226691246033},{"id":"https://openalex.org/C10590036","wikidata":"https://www.wikidata.org/wiki/Q417664","display_name":"Exome","level":5,"score":0.5958033204078674},{"id":"https://openalex.org/C51679486","wikidata":"https://www.wikidata.org/wiki/Q380546","display_name":"DNA sequencing","level":3,"score":0.5715137124061584},{"id":"https://openalex.org/C24432333","wikidata":"https://www.wikidata.org/wiki/Q2068526","display_name":"Whole genome sequencing","level":4,"score":0.5531415939331055},{"id":"https://openalex.org/C109825262","wikidata":"https://www.wikidata.org/wiki/Q1139164","display_name":"Germline","level":3,"score":0.5415925979614258},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5351311564445496},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.44344788789749146},{"id":"https://openalex.org/C141231307","wikidata":"https://www.wikidata.org/wiki/Q7020","display_name":"Genome","level":3,"score":0.41928985714912415},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.4091491103172302},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.3854749798774719},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.32755905389785767},{"id":"https://openalex.org/C501734568","wikidata":"https://www.wikidata.org/wiki/Q42918","display_name":"Mutation","level":3,"score":0.20422935485839844},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.14492931962013245}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:3023123785","doi":"https://doi.org/10.1182/blood.v130.suppl_1.392.392","is_oa":false,"landing_page_url":"https://ashpublications.org/blood/article/130/Supplement%201/392/71611/Next-Generation-Sequencing-Identifies-Smoldering","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":null,"raw_source_name":"Blood","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.6399999856948853}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2603620672","https://openalex.org/W2967350841","https://openalex.org/W2965135316","https://openalex.org/W2974881178","https://openalex.org/W2922139564","https://openalex.org/W2909521991","https://openalex.org/W2609866542","https://openalex.org/W2596886621","https://openalex.org/W2562152026","https://openalex.org/W2921802097","https://openalex.org/W3162849638","https://openalex.org/W2553725944","https://openalex.org/W2986425974","https://openalex.org/W2564149473","https://openalex.org/W3130427604","https://openalex.org/W2244438265","https://openalex.org/W2011565200","https://openalex.org/W2978491622","https://openalex.org/W2766384413","https://openalex.org/W2323658816"],"abstract_inverted_index":{"Abstract":[0],"Introduction:":[3],"Multiple":[4,27],"myeloma":[5],"(MM)":[6],"is":[7,282],"an":[8,540,558,579,591,603,615],"incurable":[9],"plasma":[10],"cell":[11],"malignancy":[12],"that":[13,53,461,487],"arises":[14],"from":[15,34,60,74,415,434],"the":[16,81,159,204,258,285,475],"precursor":[17],"states:":[18],"Monoclonal":[19],"Gammopathy":[20],"of":[21,87,109,127,144,287,342,360,385,409,422,430,437,443,474,495,543,561,582,594,606,618],"Undetermined":[22],"Significance":[23],"(MGUS)":[24],"and":[25,50,57,84,120,129,179,188,212,226,245,250,362,389,469,493,516],"Smoldering":[26],"Myeloma":[28],"(SMM).":[29],"Some":[30],"patients":[31,296,325,361,399,436,452,497],"rapidly":[32],"progress":[33],"MGUS/SMM":[35],"to":[36,97,157,181,203,257,284,294,327,417,450,477],"MM,":[37,292,418],"while":[38],"others":[39],"remain":[40],"indolent":[41],"with":[42,164,172,221,366,467,503],"minimal":[43],"progression":[44,478],"over":[45],"their":[46],"lifetime.":[47],"The":[48],"genetic":[49],"molecular":[51],"factors":[52],"underlie":[54],"disease":[55],"evolution":[56],"distinguish":[58],"progressors":[59],"non-progressors":[61],"are":[62,465],"not":[63],"well":[64,149],"elucidated.":[65],"To":[66],"address":[67],"these":[68],"questions,":[69],"we":[70,426],"examined":[71],"clinically-annotated":[72],"samples":[73,79,113,126,147,156,433],"SMM":[75,82,100,131,146,248,252,387,416,480,496],"patients,":[76,280],"including":[77,238],"sequential":[78,410],"at":[80,85],"stage":[83],"time":[86],"progression.":[88],"Methods:":[90],"We":[91,103,136],"utilized":[92],"next":[93,488],"generation":[94,489],"sequencing":[95,107,123,142,490],"methods":[96],"study":[98,485],"186":[99],"patient":[101,411],"samples.":[102],"performed":[104,138,428],"whole":[105,183],"exome":[106,184],"(WES)":[108],"70":[110],"tumor-germline":[111],"matched":[112],"(mean":[114,132],"target":[115,133,206],"coverage":[116,134],"50X/100X":[117],"for":[118],"germline/tumor)":[119],"targeted":[121,165,196],"deep":[122],"on":[124,191,539,557,578,590,602,614],"116":[125,145],"progressor":[128],"non-progressor":[130],"~500X).":[135],"also":[137,364],"ultra-low":[139],"pass":[140],"whole-genome":[141],"(ULP-WGS)":[143],"as":[148,150,511],"20":[151,435],"available":[152,431],"cell-free":[153],"DNA":[154],"(cfDNA)":[155],"detect":[158],"tumor":[160,441],"fraction":[161,442],"before":[162],"proceeding":[163],"sequencing.":[166],"For":[167,195,216],"WES,":[168],"libraries":[169,198,218],"were":[170,199,219,231,254,310,338,356,363,381,390],"constructed":[171],"Agilent":[173],"SureSelect":[174],"XT2":[175],"library":[176],"prep":[177],"kit,":[178],"hybridized":[180],"Agilent's":[182],"V5+UTR":[185],"capture":[186],"probes":[187],"then":[189],"sequenced":[190],"HiSeq":[192],"4000":[193],"(Illumina).":[194],"sequencing,":[197],"enriched":[200],"by":[201,261],"hybridizing":[202],"customized":[205],"bait":[207],"(60":[208],"MM":[209,375],"related":[210],"genes":[211,334],"56":[213],"pan-cancer":[214],"genes).":[215],"ULP-WGS,":[217],"prepared":[220],"Kapa":[222],"Hyper":[223],"Prep":[224],"kit":[225],"custom":[227],"adapters.":[228],"Sequencing":[229],"data":[230,459],"analyzed":[232],"using":[233],"previously":[234],"established":[235],"analytic":[236],"pipelines":[237],"ichorCNA,":[239],"MuTect,":[240],"RecapSeg,":[241],"MutSig,":[242],"GISTIC,":[243],"ABSOLUTE,":[244],"PHYLOGIC.":[246],"High-risk":[247],"(HRSMM)":[249],"low-risk":[251],"(LRSMM)":[253],"defined":[255],"according":[256],"criteria":[259],"proposed":[260],"Rajkumar":[262],"et":[263],"al.":[264],"in":[265,278,290,306,323,331,340,346,353,358,383,395,447,479],"Blood":[266],"2014.":[267],"Results:":[269],"Higher":[270],"mutation":[271,512],"load":[272],"(average":[273,297],"1.44":[274],"mutations/Mb)":[275],"was":[276,445],"observed":[277,311],"HRSMM":[279,324,343,367,396,448,468,504],"which":[281],"close":[283],"average":[286],"1.6":[288],"mutations/Mb":[289],"symptomatic":[291],"compared":[293,326,449],"LRSMM":[295,328,347,398,451,506],"0.73":[298],"mutations/Mb,":[299],"p":[300],"-value":[301],"=":[302,321,350,373,405,455],"0.001).":[303],"Somatic":[304],"mutations":[305],"known":[307],"signaling":[308],"pathways":[309],"four":[312],"times":[313,392],"more":[314,393],"frequently":[315,394],"(43.8%":[316],"vs.":[317,344,369,401],"9.5%,":[318],"p-":[319,371,403],"value":[320,349,372,404,454],"0.015)":[322],"patients.":[329,481],"Mutations":[330,352],"MAPK":[332],"pathway":[333,355],"(KRAS,":[335],"NRAS,":[336],"BRAF)":[337],"detected":[339,382],"21.7%":[341],"0%":[345],"(p-":[348,453],"0.004).":[351],"NFkB":[354],"present":[357],"10%":[359],"associated":[365,466,502],"(17.4%":[368],"0%,":[370],"0.018).":[374],"somatic":[376,514],"copy":[377],"number":[378],"aberrations":[379],"(SCNAs)":[380],"64%":[384],"all":[386],"samples,":[388,412],"two":[391],"than":[397],"(78.1%":[400],"42.9%,":[402],"0.020).":[406],"Phylogenetic":[407],"studies":[408],"who":[413],"progressed":[414],"revealed":[419],"different":[420,508],"patterns":[421],"clonal":[423],"evolution.":[424],"Furthermore,":[425],"have":[427],"ULP-WGS":[429],"cfDNA":[432,444],"this":[438,458],"cohort.":[439],"Interestingly,":[440],"higher":[446],"0.03).":[456],"Together,":[457],"suggests":[460],"specific":[462],"genomic":[463,500],"alterations":[464,501],"could":[470],"potentially":[471],"be":[472],"predictive":[473],"risk":[476],"Conclusion:":[483],"This":[484],"demonstrates":[486],"(WES,":[491],"targeted-sequencing,":[492],"ULP-WGS)":[494],"can":[498],"identify":[499],"vs":[505],"through":[507],"parameters":[509],"such":[510],"load,":[513],"mutations,":[515],"SCNAs.":[517],"Disclosures":[521],"Laubach:":[523],"Novartis,":[524,528,634],"Takeda,":[525,529],"Celgene:":[526,550],"Consultancy;":[527,657],"Celgene,":[530,628,644],"Onyx:":[531],"Research":[532,548,552,568,642],"Funding.":[533,569],"Richardson:":[534],"Jazz":[535],"Pharmaceuticals:":[536,612],"Consultancy,":[537,551,567],"Membership":[538,556,577,589,601,613],"entity's":[541,559,580,592,604,616],"Board":[542,560,581,593,605,617],"Directors":[544,562,583,595,607,619],"or":[545,563,584,596,608,620],"advisory":[546,564,585,597,609,621],"committees,":[547],"Funding;":[549,553,643],"Oncopeptides":[554],"AB:":[555],"committees;":[565,586,598,610,622],"Takeda:":[566,656],"Anderson:":[570],"C4":[571],"Therapeutics:":[572],"Other:":[573,624],"scientific":[574,625],"founder;":[575],"MedImmune:":[576],"Gilead":[587],"Sciences:":[588],"Bristol-Myers":[599],"Squibb:":[600],"Millenium":[611],"Oncopep:":[623],"founder.":[626],"Kumar:":[627],"Millennium/Takeda,":[629],"Onyx,":[630,647],"AbbVie,":[631,650],"Janssen,":[632,648],"Sanofi,":[633],"Amgen,":[635,651],"Genentech,":[636],"Merck,":[637,652],"Oncopeptides,":[638,653],"Roche,":[639],"Skyline":[640,654],"Diagnostics:":[641],"Millennium,":[645],"BMS,":[646],"Noxxon,":[649],"Diagnostics,":[655],"Skyline:":[658],"Honoraria.":[659]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":1}],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2025-10-10T00:00:00"}